COVID-19 VaccinE Response in Rheumatology Patients

Clinical trial NCT05080218 · COMPLETED

Trial details

NCT number: NCT05080218
Sponsor: Jeffrey Curtis
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis Psoriatic Arthritis Spondylarthritis

Start date: 2021-11-15
Primary completion: 2024-04-04
Enrollment: 841

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.